Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | March 15, 2023 09:06am

Gainers

  • ThermoGenesis Holdings (NASDAQ:THMO) stock moved upwards by 138.9% to $5.04 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.2 million.
  • Silence Therapeutics (NASDAQ:SLN) stock rose 58.9% to $15.35. The company's market cap stands at $550.9 million. As per the news, the Q4 earnings report came out today.
  • Jounce Therapeutics (NASDAQ:JNCE) stock increased by 35.84% to $1.44. The market value of their outstanding shares is at $75.0 million.
  • NeuroOne Medical Tech (NASDAQ:NMTC) stock increased by 17.19% to $1.84. The company's market cap stands at $30.1 million.
  • Elevation Oncology (NASDAQ:ELEV) shares moved upwards by 15.38% to $1.65. The market value of their outstanding shares is at $39.0 million. The company's, Q4 earnings came out 4 days ago.
  • Incannex Healthcare (NASDAQ:IXHL) stock increased by 9.95% to $2.54. The company's market cap stands at $161.2 million.

Losers

  • Bellicum Pharmaceuticals (NASDAQ:BLCM) shares fell 38.4% to $0.53 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.5 million.
  • Lannett (NYSE:LCI) stock fell 15.17% to $1.51. The market value of their outstanding shares is at $16.2 million.
  • Xtant Medical Hldgs (AMEX:XTNT) stock decreased by 13.41% to $0.6. The company's market cap stands at $65.3 million.
  • Celyad Oncology (NASDAQ:CYAD) shares decreased by 13.4% to $0.85. The company's market cap stands at $19.2 million.
  • Addex Therapeutics (NASDAQ:ADXN) stock fell 12.31% to $1.14. The market value of their outstanding shares is at $21.9 million. The company's, Q4 earnings came out 2 days ago.
  • Unicycive Therapeutics (NASDAQ:UNCY) shares fell 12.22% to $1.94. The company's market cap stands at $29.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADXN BLCM CYAD ELEV IXHL JNCE LCI NMTC SLN THMO UNCY XTNT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist